News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region – VHIO
Vall d’Hebron Institute of Oncology/X
Apr 11, 2025, 05:18

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region – VHIO

Vall d’Hebron Institute of Oncology (VHIO) shared a post on X:

“Published today at Cancer Discovery an international study led by ToledoLab VHIO at VHIO describes that oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region.”

Bruna Calsina, Adjunct professor at Autonomous University of Barcelona, reshared the post on X, adding:

“Big paper out today in Cancer Discovery!

As ToledoLab VHIO & Carlota say: from tumors to mountains-genetic convergence in low O₂ adaptation & cancer evolution reveals insights into cancer & potential targets.

Grateful to be part of this story!”

Convergent Genetic Adaptation in Human Tumors Developed Under Systemic Hypoxia and in Populations Living at High Altitudes.

Authors: Carlota Arenillas, et al.

Oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region - VHIO

Bruna Calsina cancer Cancer Cells Cancer Discovery Carlota Arenillas fight against cancer Global fight against cancer OncoDaily Oncology Sherpa population Systemic Hypoxia ToledoLab VHIO University of Barcelona Vall d’Hebron Institute of Oncology VHIO
Special Coverage
Blog
May 21, 2025, 17:25
Rick Buck Presents on AACR Collaboration at Cancer Marketing and Communications Association Meeting
Insight
May 21, 2025, 17:20
Lung Cancer Europe shared study on short-term prehabilitation in resectable NSCLC patients
Insight
May 21, 2025, 17:12
Tanja Obradovic: Issue of Trial Data Applicability to US Patient Population is Resurfacing Again at FDA
Societies
May 21, 2025, 17:07
The American Society of Hematology: Join May 30 webinar on VUS challenges in germline testing
Science
May 21, 2025, 16:57
Guru Sonpavde: CheckMate 901 Trial Data on First-Line Nivolumab in LN-Only Metastatic Urothelial Carcinoma
Blog
May 21, 2025, 16:48
How Can We Build Trust in New Cancer Tools Like Liquid Biopsies? - Lung Cancer Europe
Blog
May 21, 2025, 16:43
The Ohio State’s James Cancer Hospital and Solove Research Institute Represented at the 2025 Race for the Cure
Blog
May 21, 2025, 16:42
Estelamari Rodriguez: Celebrating Clinical Trials Day with the Best Research Staff
Insight
May 21, 2025, 16:38
Catherine Alix-Panabières highlights French-Japanese collaboration on liquid biopsy research in Montpellier
Blog
May 21, 2025, 16:34
Sumanta Pal: The Evolution of Treatments For Prostate Cancer Over The Past 2 Decades
Blog
May 21, 2025, 16:12
Equal Chances at Life for Children and Young Adults with Cancer Begin with Health Investment - SIOP Europe
Societies
May 21, 2025, 16:00
World Child Cancer USA joined ACT for Children initiative to improve pediatric cancer care in LMICs